Titan Pharmaceuticals
TTNP
#10414
Rank
$6.13 M
Marketcap
$4.61
Share price
-3.76%
Change (1 day)
22.93%
Change (1 year)

Titan Pharmaceuticals (TTNP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $0.26 Million USD

According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are $0.26 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.48 M-66.55%
2023-12-31$1.44 M-46.42%
2022-12-31$2.69 M-5.64%
2021-12-31$2.85 M-37.3%
2020-12-31$4.55 M-43.69%
2019-12-31$8.08 M11.36%
2018-12-31$7.26 M-9.74%
2017-12-31$8.04 M46.97%
2016-12-31$5.47 M-13.04%
2015-12-31$6.29 M-48.55%
2014-12-31$12.24 M-3.34%
2013-12-31$12.66 M-73.59%
2012-12-31$47.95 M58.29%
2011-12-31$30.29 M180.39%
2010-12-31$10.8 M174.73%
2009-12-31$3.93 M
2007-12-31$4.25 M25.4%
2006-12-31$3.39 M8.23%
2005-12-31$3.13 M-14.6%
2004-12-31$3.67 M9.91%
2003-12-31$3.34 M-15.31%
2002-12-31$3.94 M-31.56%
2001-12-31$5.76 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
$0.13 B 51,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
$2.96 M 1,028.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$50.07 M 18,940.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 43,170,622.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 23,778,227.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
$0.84 B 319,528.90%๐Ÿ‡บ๐Ÿ‡ธ USA